RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/31515941http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/31515941http://www.w3.org/2000/01/rdf-schema#comment"Interleukin-6 (IL-6) is a growth factor for normal B cells and plasma cell-derived malignancies. Here, we show that the IL-6 signaling pathway is also active in a subset of diffuse large B-cell lymphoma (DLBCL) patients with particularly poor prognosis. Primary DLBCL cells and DLBCL cell lines expressing IL-6R engraft and form orthotopic lymphomas in humanized mice that ectopically produce human IL-6, and in mice reconstituted with a human immune system. We show that a subset of DLBCL cases have evolved mechanisms that ensure constitutive activation of the IL-6 signaling pathway, i.e., the expression of both chains of the IL-6R, the expression of the cytokine itself, and the mutational inactivation of a negative regulator of IL-6 signaling, SOCS1. IL-6 signaling promotes MYC-driven lymphomagenesis in a genetically engineered model, and treatment with the IL-6R-specific antibody tocilizumab reduces growth of primary DLBCL cells and of DLBCL cell lines in various therapeutic settings. The combined results uncover the IL-6 signaling pathway as a driver and negative prognosticator in aggressive DLBCL that can be targeted with a safe and well-tolerated biologic."xsd:string
http://purl.uniprot.org/citations/31515941http://purl.org/dc/terms/identifier"doi:10.15252/emmm.201910576"xsd:string
http://purl.uniprot.org/citations/31515941http://purl.uniprot.org/core/author"Muller A."xsd:string
http://purl.uniprot.org/citations/31515941http://purl.uniprot.org/core/author"Bertram K."xsd:string
http://purl.uniprot.org/citations/31515941http://purl.uniprot.org/core/author"Wu C.T."xsd:string
http://purl.uniprot.org/citations/31515941http://purl.uniprot.org/core/author"Manz M.G."xsd:string
http://purl.uniprot.org/citations/31515941http://purl.uniprot.org/core/author"Stelling A."xsd:string
http://purl.uniprot.org/citations/31515941http://purl.uniprot.org/core/author"Tzankov A."xsd:string
http://purl.uniprot.org/citations/31515941http://purl.uniprot.org/core/author"Theocharides A.P."xsd:string
http://purl.uniprot.org/citations/31515941http://purl.uniprot.org/core/author"Hashwah H."xsd:string
http://purl.uniprot.org/citations/31515941http://purl.uniprot.org/core/author"Kasser S."xsd:string
http://purl.uniprot.org/citations/31515941http://purl.uniprot.org/core/author"Stirm K."xsd:string
http://purl.uniprot.org/citations/31515941http://purl.uniprot.org/core/date"2019"xsd:gYear
http://purl.uniprot.org/citations/31515941http://purl.uniprot.org/core/name"EMBO Mol Med"xsd:string
http://purl.uniprot.org/citations/31515941http://purl.uniprot.org/core/pages"e10576"xsd:string
http://purl.uniprot.org/citations/31515941http://purl.uniprot.org/core/title"The IL-6 signaling complex is a critical driver, negative prognostic factor, and therapeutic target in diffuse large B-cell lymphoma."xsd:string
http://purl.uniprot.org/citations/31515941http://purl.uniprot.org/core/volume"11"xsd:string
http://purl.uniprot.org/citations/31515941http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/31515941
http://purl.uniprot.org/citations/31515941http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/31515941
http://purl.uniprot.org/uniprot/#_A0A087WTB5-mappedCitation-31515941http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31515941
http://purl.uniprot.org/uniprot/#_A0A0G2JGF1-mappedCitation-31515941http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31515941
http://purl.uniprot.org/uniprot/#_A0A0G2JGF4-mappedCitation-31515941http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31515941
http://purl.uniprot.org/uniprot/#_E0CXQ9-mappedCitation-31515941http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31515941
http://purl.uniprot.org/uniprot/#_Q0PMN1-mappedCitation-31515941http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31515941